Wednesday, July 30, 2008
Teva Introduces Divalproex Sodium Delayed-Release Tablets USP
July 29, 2008 – Teva Pharmaceuticals is pleased to announce the introduction and availability of Divalproex Sodium Delayed-Release Tablets USP. This product is AB rated and bioequivalent to Depakote®* Tablets. Divalproex Sodium Delayed-Release Tablets are available in 125 mg strength, in bottles sizes of 100, and in 250 mg and 500 mg strengths, in bottle sizes of 100 and 500.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment